Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Avastin bevacizumab: Phase III started

Last quarter, the partners began the 1,060-patient Phase III MAIN trial

Read the full 110 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE